The benchmark petered out on Friday, with SaaS firms still out of favour.
Land and loans associated with defunct infant formula project are now in the hands of NZX-listed asset manager.
One analyst believes the retirement village operator ought to consider a cap raise to help grow in Australia.
Sales improve but rising costs and lower demand from key customers segments affect HY result.
Listed transport and logistics company puts a sharp focus on cutting costs and improving margins.
The company expects its annual operating profit to come in at the lower end of guidance.
The NZX-listed medicinal cannabis company still has cashflow pressures.
Crescent Capital Partners offered 8c a share last December, valuing the business at about $14.8m.
NZX-listed media company NZME announced a strategic review of its property listing business yesterday.
The company says it is still ‘rebuilding trust’ with customers.
